Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in colorectal cancer through ERK and β-arrestin pathways

International Journal of Oncology

Volumn 45, Issue 4, 2014, Pages 1649-1657

  Li, Xin Xiang ^a,b   Zheng, Hong Tu ^a,b   Huang, Li Yong ^a,b   Shi, De Bing ^a,b   Peng, Jun Jie ^a,b   Liang, Lei ^a,b   Cai, San Jun ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Colorectal cancer; CXCR7; Growth; Invasion

Indexed keywords

BETA ARRESTIN; CASPASE 3; CHEMOKINE RECEPTOR CXCR7; COLLAGEN TYPE 4; CYCLINE; GELATINASE A; LAMININ; MATRIX METALLOPROTEINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; CHEMOKINE RECEPTOR CXCR; CMKOR1 PROTEIN, MOUSE; CXCR7 PROTEIN, HUMAN; RETINA S ANTIGEN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; CANCER INHIBITION; CANCER STAGING; CELL INVASION; CELL MEMBRANE; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR INVASION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; AGED; ANIMAL; CANCER TRANSPLANTATION; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; HT 29 CELL LINE; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AGED; ANIMALS; ARRESTINS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HT29 CELLS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RECEPTORS, CXCR;

EID: 84907451363     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2547     Document Type: Article

References (33)

1. Wani HA, Beigh MA, Amin S, et al: Methylation profile of promoter region of p16 gene in colorectal cancer patients of Kashmir valley. J Biol Regul Homeost Agents 27: 297-307, 2013.
2. Kheirelseid EA, Miller N, Chang KH, et al: Clinical applications of gene expression in colorectal cancer. J Gastrointest Oncol 4: 144-57, 2013.
3. Liao YX, Zhou CH, Zeng H, et al: The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review). Int J Mol Med 32: 1239-1246, 2013.
4. Ratajczak MZ, Kim C, Janowska-Wieczorek A, et al : The expanding family of bone marrow homing factors for hematopoietic stem cells: stromal derived factor 1 is not the only player in the game. Sci World J 2012: 758512, 2012.
5. Wang L, Chen W, Gao L, et al: High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma. World J Surg Oncol 10: 212, 2012.
6. Monnier J, Boissan M, L'Helgoualc'h A, et al: CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. Eur J Cancer 48: 138-148, 2012.
7. Hattermann K, Held-Feindt J, Lucius R, et al: The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res 70: 3299-3308, 2010.
8. Gahan JC, Gosalbez M, Yates T, et al: Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis. J Urol 187: 827-833, 2012.
9. Liu Z, Sun DX, Teng XY, et al: Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma. Endocr Pathol 23: 247-253, 2012.
10. Ehrlich A, Ray P, Luker KE, et al: Allosteric peptide regulators of chemokine receptors CXCR4 and CXCR7. Biochem Pharmacol 86: 1263-1271, 2013.
11. Hattermann K and Mentlein R: An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology. Ann Anat 195: 103-110, 2013.
12. Schrevel M, Karim R, ter Haar NT, et al: CXCR7 expression is associated with disease-free and disease-specific survival in cervical CXCR7 patients. Br J Cancer 106: 1520-1525, 2012.
13. Odemis V, Lipfert J, Kraft R, et al: The presumed atypical chemokine receptor CXCR7 signals through G (i/o) proteins in primary rodent astrocytes and human glioma cells. Glia 60: 372-381, 2012.
14. Wijtmans M, Maussang D, Sirci F, et al: Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists. Eur J Med Chem 51: 184-192, 2012.
15. Maussang D, Mujić-Delić A, Descamps FJ, et al: Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo. J Biol Chem 288: 29562-29572, 2013.
16. McGinn OJ, Marinov G, Sawan S, et al : CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofoetal glycoprotein. J Cell Sci 125: 5467-5478, 2012.
17. Hao M, Zheng J, Hou K, et al: Role of chemokine receptor CXCR7 in bladder cancer progression. Biochem Pharmacol 84: 204-214, 2012.
18. Tang T, Xia QJ, Chen JB, et al: Expression of the CXCL12/SDF-1 chemokine receptor CXCR7 in human brain tumours. Asian Pac J Cancer Prev 13: 5281- 5286, 2012.
19. Goguet-Surmenian E, Richard-Fiardo P, Guillemot E, et al: CXCR7-mediated progression of osteosarcoma in the lungs. Br J Cancer 109: 1579-1585, 2013.
20. Gebauer F, Tachezy M, Effenberger K, et al: Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma. J Surg Oncol 104: 140-145, 2011.
21. Guo JC, Li J, Yang YC, et al: Oligonucleotide microarray identifies genes differentially expressed during tumorigenesis of DMBA-induced pancreatic cancer in rats. PLoS One 8: e82910, 2013.
22. Baumhoer D, Smida J, Zillmer S, et al: Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma. Mod Pathol 25: 522-528, 2012.
23. Zabel BA, Lewén S, Berahovich RD, et al: The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells. Mol Cancer 10: 73, 2011.
24. Zheng K, Li HY, Su XL, et al: Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells. J Exp Clin Cancer Res 29: 31, 2010.
25. Hattermann K, Mentlein R and Held-Feindt J: CXCL12 mediates apoptosis resistance in rat C6 glioma cells. Oncol Rep 27: 1348-1352, 2012.
26. Guillemot E, Karimdjee-Soilihi B, Pradelli E, et al: CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver. Br J Cancer 107: 1944-1949, 2012.
27. Heinrich EL, Lee W, Lu J, et al: Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells J Transl Med 10: 68, 2012.
28. Ray P, Mihalko LA, Coggins NL, et al: Carboxy-terminus of CXCR7 regulates receptor localization and function. Int J Biochem Cell Biol 44: 669-678, 2012.
29. Liu L, Zhao X, Zhu X, et al: Decreased expression of miR-430 promotes the development of bladder cancer via the upregulation of CXCR7. Mol Med Rep 8: 140-146, 2013.
30. Risio M: Cell proliferation in colorectal tumor progression: an immunohistochemical approach to intermediate biomarkers. J Cell Biochem (Suppl) 16G: 79-87, 1992.
31. Liabakk NB, Talbot I, Smith RA, et al: Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 56: 190-196, 1996. (Pubitemid 26010399)
32. Devarajan E, Sahin AA, Chen JS, et al: Downregulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 21: 8843-8851, 2002. (Pubitemid 36132404)
33. Dong S, Kong J, Kong F, et al: Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways. J Transl Med 11: 273, 2013.